Back to Goldman Sachs Group Inc. Goldman Sachs Group Inc.

SMMT

17 quarters

Position history for Goldman Sachs Group Inc.Goldman Sachs Group Inc.'s holdings in Summit Therapeutics Inc.

Yes. Goldman Sachs holds 4,513,399 shares of SMMT (Summit Therapeutics), worth $65.8M, as of its Q2 2026 13F filing. It increased the position from 310,728 shares in Q1 2026. Goldman Sachs has held SMMT in every 13F on record since Q2 2022, 17 quarterly filings.

Current Value

$65.8M

Current Shares

4.5M

Total Value Change

+$65.7M

Total Shares Change

+4.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.5M
+1352.5%
$65.8M0.0%$14.57
48
2026-Q1
Decreased
310,728
-36.0%
$5.9M0.0%$15.11
0
2025-Q4
Decreased
485,566
-2.4%
$8.5M0.0%$17.49
0
2025-Q3
Increased
497,547
+64.0%
$10.3M0.0%$20.66
40
2025-Q2
Decreased
303,426
-47.0%
$6.5M0.0%$21.28
0
2025-Q1
Decreased
572,791
-37.1%
$11M0.0%$19.29
0
2024-Q4
Increased
910,002
+83.7%
$16.2M0.0%$17.85
44
2024-Q3
Increased
495,355
+9.1%
$10.8M0.0%$21.90
30
2024-Q2
Decreased
453,944
-33.3%
$3.5M0.0%$7.80
0
2024-Q1
Increased
680,601
+250.1%
$2.8M0.0%$4.14
42
2023-Q4
Increased
194,408
+1.1%
$507,4040.0%$2.61
24
2023-Q3
Decreased
192,198
-45.2%
$359,4100.0%$1.87
0
2023-Q2
Decreased
351,002
-20.4%
$881,0150.0%$2.51
0
2023-Q1
Increased
440,889
+694.2%
$771,5560.0%$1.75
40
2022-Q4
Decreased
55,511
-8.6%
$235,9220.0%$4.25
0
2022-Q3
Increased
60,740
+76.6%
$72,0000.0%$1.19
22
2022-Q2
First report
34,393
-
$34,0000.0%$1.00
0

Other major holders of SMMT: Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used